Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.

@article{Zivanovic2009StagespecificOO,
  title={Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.},
  author={Oliver Zivanovic and Mario M M Leitao and Alexia Iasonos and Lindsay M. Jacks and Qin C. Zhou and Nadeem R. Abu-Rustum and Robert A Soslow and Margrit M Juretzka and Dennis Chi and Richard R. Barakat and Murray F. Brennan and Martee L. Hensley},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 12},
  pages={
          2066-72
        }
}
PURPOSE Uterine leiomyosarcoma (LMS) is staged by the modified International Federation of Gynecology and Obstetrics (FIGO) staging system for uterine cancer. We aimed to determine whether the American Joint Committee on Cancer (AJCC) soft tissue sarcoma (STS) staging system is more accurate in predicting progression-free survival (PFS) and overall survival (OS). PATIENTS AND METHODS Patients with uterine LMS who presented at our institution from 1982 to 2005 were staged retrospectively… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Similar Papers

Loading similar papers…